Login / Signup
What could be the better choice between ACE inhibitors and AT1R antagonists in coronavirus disease 2019 (COVID-19) patients?
Guglielmina Froldi
Published in:
Journal of medical virology (2020)
Keyphrases
</>
coronavirus disease
sars cov
angiotensin converting enzyme
angiotensin ii
respiratory syndrome coronavirus
decision making